Video
Video
06/14/2024
Michael J. Bloch, MD
In this video, Michael J. Bloch, MD, discusses any cardiovascular benefits to the use of estrogen-free oral contraceptives in women, including a recently published study on the association of menstrual...
06/14/2024
Video
Video
06/14/2024
Michael J. Bloch, MD
In this video, Michael J. Bloch, MD, discusses any cardiovascular benefits to the use of estrogen-free oral contraceptives in women, including a recently published study on the association of menstrual...
06/14/2024
Video
Video
06/14/2024
Michael J. Bloch, MD
In this video, Michael J. Bloch, MD, discusses any cardiovascular benefits to the use of estrogen-free oral contraceptives in women, including a recently published study on the association of menstrual...
06/14/2024
Video
Video
06/14/2024
Michael J. Bloch, MD
In this video, Michael J. Bloch, MD, discusses any cardiovascular benefits to the use of estrogen-free oral contraceptives in women, including a recently published study on the association of menstrual...
06/14/2024
Video
Video
06/11/2024

Kathryn Kreider, DNP, APRN, FAANP, FNP-BC

Kathryn Kreider, DNP, APRN, FAANP, FN...
In this video, Kathryn Kreider, DNP, APRN, FAANP, FNP-BC, speaks about the use of glucagon-like peptide-1 (GLP-1s) agonists in patients with type 2 diabetes (T2D) and obesity, including how the medication...
06/11/2024
Video
Video
06/11/2024

Kathryn Kreider, DNP, APRN, FAANP, FNP-BC

Kathryn Kreider, DNP, APRN, FAANP, FN...
In this video, Kathryn Kreider, DNP, APRN, FAANP, FNP-BC, speaks about the use of glucagon-like peptide-1 (GLP-1s) agonists in patients with type 2 diabetes (T2D) and obesity, including how the medication...
06/11/2024
Video
Video
06/11/2024

Kathryn Kreider, DNP, APRN, FAANP, FNP-BC

Kathryn Kreider, DNP, APRN, FAANP, FN...
In this video, Kathryn Kreider, DNP, APRN, FAANP, FNP-BC, speaks about the use of glucagon-like peptide-1 (GLP-1s) agonists in patients with type 2 diabetes (T2D) and obesity, including how the medication...
06/11/2024
Video
Video
06/11/2024

Kathryn Kreider, DNP, APRN, FAANP, FNP-BC

Kathryn Kreider, DNP, APRN, FAANP, FN...
In this video, Kathryn Kreider, DNP, APRN, FAANP, FNP-BC, speaks about the use of glucagon-like peptide-1 (GLP-1s) agonists in patients with type 2 diabetes (T2D) and obesity, including how the medication...
06/11/2024
Video
Video
06/11/2024

Kathryn Kreider, DNP, APRN, FAANP, FNP-BC

Kathryn Kreider, DNP, APRN, FAANP, FN...
In this video, Kathryn Kreider, DNP, APRN, FAANP, FNP-BC, speaks about the use of glucagon-like peptide-1 (GLP-1s) agonists in patients with type 2 diabetes (T2D) and obesity, including how the medication...
06/11/2024
Video
Video
06/11/2024

Kathryn Kreider, DNP, APRN, FAANP, FNP-BC

Kathryn Kreider, DNP, APRN, FAANP, FN...
In this video, Kathryn Kreider, DNP, APRN, FAANP, FNP-BC, speaks about the use of glucagon-like peptide-1 (GLP-1s) agonists in patients with type 2 diabetes (T2D) and obesity, including how the medication...
06/11/2024